Trial Profile
Assessment of dose response of LY333334 [teriparatide] in Japanese postmenopausal women with osteoporosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2005
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 05 Nov 2005 New trial record.